已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Association of PCI with outcomes in stable coronary artery disease

医学 传统PCI 冠状动脉疾病 心脏病学 内科学 联想(心理学) 经皮冠状动脉介入治疗 心肌梗塞 认识论 哲学
作者
J Price,Michael Tao,Saurabh Kumar Gupta,Chad Gier,Paola Pastena,Ishmam Ibtida,Asha Sharma,Noelle Nora Mann
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:45 (Supplement_1)
标识
DOI:10.1093/eurheartj/ehae666.1442
摘要

Abstract Background The utility of percutaneous coronary intervention (PCI) in patients with stable symptomatic coronary artery disease (CAD) remains unclear. Although there has been recent literature to suggest that PCI may improve anginal symptoms, studies evaluating the association of PCI with clinical outcomes compared to optimal medical therapy (OMT) has yielded conflicting results. Purpose We performed a systematic review and meta-analysis evaluating the association of PCI compared to OMT with adverse cardiovascular outcomes in patients with stable CAD. Methods A literature search was performed using the databases Ovid MEDLINE, Embase, and Web of Science, identifying studies that evaluated the association of PCI with clinical endpoints in patients with symptomatic stable CAD. The primary endpoint was all-cause mortality. Secondary endpoints were recurrent acute myocardial infarction (AMI), cerebrovascular accident (CVA), and unplanned coronary revascularization. The search was not restricted to time or publication status. Results A total of 17 studies with 20,389 patients (11,294 PCI, 9095 OMT) met inclusion criteria. Mean follow-up duration was 3.98 years (ranging from 1 year to 6.5 years), mean age was 63.8, mean ejection fraction was 59%. All patients had symptomatic CAD with lesion severity >50%. Compared to OMT, PCI was associated with lower risk of mortality on short-term (≤1 year) but not long-term (>1 year) follow-up (OR 0.5, 95% CI 0.29-0.86; p=0.01; OR 0.68; 95% CI 0.42-1.12; p=0.88). PCI was not associated with lower risk of AMI or need for unplanned coronary revascularization (OR 1.02; 95% CI 0.73-1.44; p=0.90; OR 0.87; 95% CI 0.51-1.49; p=0.61). There was a trend toward lower risk of CVA in patients treated with OMT compared to PCI, however this was not statistically significant (OR 1.46; 95% CI 0.96-2.22; p=0.07). Conclusions The use of PCI in patients with stable CAD is associated with lower risk of all-cause mortality on short-term follow-up, however this association was not seen on long-term follow-up >1 year. PCI was not associated with lower risk of AMI or unplanned revascularization and may be associated with increased risk of CVA compared to OMT. Additional high-quality studies are needed to further associate the utility of PCI in this patient population.Figure 1Figure 2

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
潇洒乘云发布了新的文献求助10
刚刚
Jessiehuang完成签到 ,获得积分10
刚刚
夭夭发布了新的文献求助10
1秒前
左岸关注了科研通微信公众号
1秒前
小张发布了新的文献求助10
2秒前
标致梦易发布了新的文献求助10
3秒前
Fan完成签到 ,获得积分0
3秒前
赘婿的应助被初景采纳,获得10
4秒前
cbh完成签到,获得积分10
4秒前
NexusExplorer的应助被高大的傲雪采纳,获得10
5秒前
mu完成签到 ,获得积分10
5秒前
十二一完成签到 ,获得积分10
6秒前
7秒前
哇塞的完成签到,获得积分10
8秒前
基因金完成签到,获得积分10
8秒前
疏梅居士完成签到 ,获得积分10
8秒前
我就吃一口完成签到 ,获得积分10
9秒前
10秒前
高高高的应助被龙虾采纳,获得10
10秒前
高高高的应助被龙虾采纳,获得10
10秒前
高高高的应助被龙虾采纳,获得10
11秒前
丘比特的应助被龙虾采纳,获得10
11秒前
高高高的应助被龙虾采纳,获得10
11秒前
颜染完成签到,获得积分10
11秒前
11秒前
寒冬星辰完成签到,获得积分10
12秒前
小张完成签到,获得积分10
12秒前
生动的孤容完成签到 ,获得积分10
12秒前
Owen的应助被独特的冰绿采纳,获得10
12秒前
柚子完成签到 ,获得积分0
12秒前
mikko完成签到,获得积分10
12秒前
共享精神的应助被标致梦易采纳,获得10
13秒前
13秒前
13秒前
14秒前
AD关注了科研通微信公众号
14秒前
今后的应助被zzl采纳,获得10
14秒前
14秒前
淡然大米完成签到 ,获得积分10
15秒前
journey完成签到 ,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Mathematical models in hydrology 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Erzählte Gnade 500
Butadiene hydroxytelechelic oligomers PBHT 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8083499
求助须知:如何正确求助?哪些是违规求助? 9498533
关于积分的说明 21407385
捐赠科研通 7651844
什么是DOI,文献DOI怎么找? 3402312
关于科研通互助平台的介绍 2531275
邀请新用户注册赠送积分活动 2440932